Cyanamide

Cyanamide

SCHEMBL15435940

C[N+]1(c2ccccc2)CCCC1.N#CN.N#CN

nearest known ligand 0.32

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.32
CHRM4 P08173 1/20 0.32
CHRM5 P08912 1/20 0.32
CHRM1 P11229 1/20 0.32
CHRM3 P20309 1/20 0.32
PABPC1 P11940 1/20 0.32
APOBEC3A P31941 1/20 0.32
EIF4H Q15056 1/20 0.32
APOBEC3G Q9HC16 1/20 0.32
LMNA P02545 1/20 0.31
HTT P42858 1/20 0.31
CYP3A4 P08684 1/20 0.31
ALOX15 P16050 1/20 0.31
CHRNB2 P17787 1/20 0.31
NFKB1 P19838 1/20 0.31
MAPK1 P28482 1/20 0.31
CHRNA3 P32297 1/20 0.31
CHRNA7 P36544 1/20 0.31
CHRNA4 P43681 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5281905 0.87 APOBEC3A (0.37) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL5944513 0.85 APOBEC3A (0.40) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL15435941 0.85 CHRM2 (0.30) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL15293601 0.68 CYP1A2 (0.43) CHRM2CHRM1CHRM3APOBEC3AAPOBEC3G
SCHEMBL5944446 0.67 ACHE (0.40) APOBEC3AAPOBEC3GLMNAHTTALDH1A1
SCHEMBL16612447 0.67 KMT2A (0.44) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL16612732 0.67 KMT2A (0.44) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL7074944 0.67 CYP3A4 (0.41) CHRM2CHRM4CHRM5CHRM1CHRM3
Cyanamide SCHEMBL9930186 0.66 TSHR (0.39) ALDH1A1TSHR
SCHEMBL5944497 0.66 POLB (0.42) APOBEC3AAPOBEC3GLMNAHTTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2690180-A1 Method for enhancing efficiency and sensitivity in nucleic acid amplification from biological materials using ionic liquids Samsung Electronics Co., Ltd (KR) 2014-01-29 EP disclosed